OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

JYNNEOS™ effectiveness as post-exposure prophylaxis against mpox: Challenges using real-world outbreak data
Jennifer B. Rosen, Robert J. Arciuolo, Preeti Pathela, et al.
Vaccine (2024) Vol. 42, Iss. 3, pp. 548-555
Closed Access | Times Cited: 15

Showing 15 citing articles:

Vaccine effectiveness of 3rd generation mpox vaccines against mpox and disease severity: A systematic review and meta-analysis
Lauren Pischel, Brett A. Martini, Natalle Yu, et al.
Vaccine (2024) Vol. 42, Iss. 25, pp. 126053-126053
Open Access | Times Cited: 18

Vaccines against Mpox: MVA-BN and LC16m8
John D. Grabenstein, Adam Hacker
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 796-811
Open Access | Times Cited: 16

Mpox Clinical Presentation, Diagnostic Approaches, and Treatment Strategies
Boghuma K Titanji, Aniruddha Hazra, Jason Zucker
JAMA (2024) Vol. 332, Iss. 19, pp. 1652-1652
Closed Access | Times Cited: 11

Effectiveness of modified vaccinia Ankara-Bavarian Nordic vaccine against mpox infection: emulation of a target trial
Christine Navarro, Cindy Lau, Sarah A. Buchan, et al.
BMJ (2024), pp. e078243-e078243
Closed Access | Times Cited: 8

Mpox 2024: New variant, new challenges, and the looming pandemic
Amogh Verma, Mahalaqua Nazli Khatib, Gopal Ashish Sharma, et al.
Clinical Infection in Practice (2024), pp. 100394-100394
Open Access | Times Cited: 6

Examining homology between MPXV and immunogenic VACV-derived peptides
Lara I Teodoro, Inna G. Ovsyannikova, Gregory A. Poland, et al.
Vaccine (2025) Vol. 48, pp. 126708-126708
Closed Access

Lack of mpox transmission in a long-term–care facility despite widespread exposure – Kentucky, 2023,
Alexandra Barger, Jennifer Duncan, Dipomin François Traoré, et al.
American Journal of Infection Control (2025)
Closed Access

MVA-BN Vaccine Effectiveness: A Systematic Review of Real-World Evidence in Outbreak Settings
Lauren M.K. Mason, Estefania Betancur, Margarita Riera-Montes, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4

Innate and adaptive immune responses that control lymph-borne viruses in the draining lymph node
Carolina R. Melo‐Silva, Luis J. Sigal
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 9, pp. 999-1007
Open Access | Times Cited: 4

MVA-BN vaccine effectiveness: A systematic review of real-world evidence in outbreak settings
Lauren M.K. Mason, Estefania Betancur, Margarita Riera-Montes, et al.
Vaccine (2024) Vol. 42, Iss. 26, pp. 126409-126409
Open Access | Times Cited: 4

Burden of Vaccine-Preventable Diseases in People Living with HIV
Hady Samaha, Arda Yigitkanli, Amal Naji, et al.
Vaccines (2024) Vol. 12, Iss. 7, pp. 780-780
Open Access | Times Cited: 1

Computational identification of monkeypox virus epitopes to generate a novel vaccine antigen against Mpox
Özge Dülek, Gökhan M. Mutlu, Ecem Su Koçkaya, et al.
Biologicals (2024) Vol. 88, pp. 101798-101798
Closed Access | Times Cited: 1

Vaccination to prevent mpox
Nick Andrews, Sema Mandal
BMJ (2024), pp. q2057-q2057
Closed Access

Page 1

Scroll to top